Search

Your search keyword '"Commerford PJ"' showing total 137 results

Search Constraints

Start Over You searched for: Author "Commerford PJ" Remove constraint Author: "Commerford PJ"
137 results on '"Commerford PJ"'

Search Results

3. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

4. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

5. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

6. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

7. Effects of calcium antagonists on hypertension and diastolic function

8. Balloon valvuloplasty for severe mitral valve stenosis in pregnancy

9. Out-of-hospital cardiac arrest

11. From the Editor’s Desk

13. From the Editor's Desk

15. WHAT IS THE RELEVANCE OF THE HOPE STUDY IN GENERAL PRACTICE?

19. Early and late effects of clopidogrel in patients with acute coronary syndromes.

20. The clopidogrel in unstable angina to prevent Recurrent Events (CURE) trial programme - Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

23. Controversies in cardiology.

24. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

26. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.

28. Covid-19 and cardiovascular disease.

29. Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

30. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

31. From the Editor's Desk.

32. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

33. From the Editor's Desk.

34. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

35. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

36. From the Editor's Desk.

37. Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.

38. Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic.

39. The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature.

40. Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study.

41. HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study.

42. Contemporary use of adjunctive corticosteroids in tuberculous pericarditis.

43. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa.

44. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

45. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry.

47. Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.

48. Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven.

49. Antihypertensive effects of angiotensin converting enzyme inhibition by lisinopril in post-transplant patients.

50. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.

Catalog

Books, media, physical & digital resources